Cardiac side-effects of cancer chemotherapy
Top Cited Papers
- 20 April 2010
- journal article
- review article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 144 (1), 3-15
- https://doi.org/10.1016/j.ijcard.2010.03.003
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- Anthracycline-Induced CardiomyopathyJournal of the American College of Cardiology, 2010
- Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoringBritish Journal of Cancer, 2009
- Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent PathwaysJournal of Biological Chemistry, 2009
- Cardiac toxicity of sunitinibThe Lancet, 2007
- Cardiotoxicity associated with tyrosine kinase inhibitor sunitinibThe Lancet, 2007
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Adjuvant Docetaxel for Node-Positive Breast CancerNew England Journal of Medicine, 2005
- Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose ChemotherapyCirculation, 2004
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2004
- Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapyAmerican Journal Of Medicine, 1987